登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>Biotin >ADC-P008

AGLink® ADC Conjugation Kit (Biotin, DAR2&4, 1mg)

For research use only.

组分(Materials Provided)

BoxA(-20°C)

IDComponentsSize
ADC-P008-C0120 x Reaction buffer50ul
ADC-P008-C02Cofactor A50ul
ADC-P008-C03Cofactor B50ul
ADC-P008-C04Substrate A25ul
ADC-P008-C05Substrate B25ul
ADC-P008-C06Enzyme A25ul
ADC-P008-C07Enzyme B25ul
ADC-P008-C08Enzyme C20ul

 

BoxB(4°C)

IDComponentsSize
ADC-P008-1-C01Binding buffer15ml
ADC-P008-1-C02Elution buffer1.5ml
ADC-P008-1-C03Neutralization buffer0.5ml
ADC-P008-1-C04250 mM Tris-HCl buffer (pH7.5)1.5ml
ADC-P008-1-C0510×PBS (pH7.2- 7.4)6ml
ADC-P008-1-C06Desalting column2per
ADC-P008-1-C07Concentrator tube2per
ADC-P008-1-C08ProteinA Resin100ul*2

背景(Background)

Antibody-drug conjugates (ADC) is a type of fast growing anticancer drug. Monoclonal antibody is conjugated to the cytotoxic payload via a chemical linker that directed toward a target antigen expressed on the cancer cell surface, reducing systemic exposure and therefore toxicity. AGLink® ADC conjugation kit is designed to conjugate mAb with Biotin though site-specific enzymatic reaction.

应用说明(Application)

AGLink® ADC Conjugation Kit (Biotin, DAR2&4, 1mg) is designed to conjugate 1mg mAb with Biotin through site-specific enzymatic reaction.

It is for research use only.

优势特色(Features)

  1. Site-specific conjugation through Fc-glycan with high conjugation efficiency
  2. Uniform DAR value and highly homogeneous ADC products
  3. No need of amino acid sequence engineering
  4. Easy to use: One-pot & One-step
  5. Two options: DAR2 & DAR4 ADC product

存储(Storage)

BoxA: The unopened kit is stable for 12 months from the date of manufacture if stored under temperature ≤ -20°C. The opened kit should be stored according to components table. BoxB: The unopened kit is stable for 12 months from the date of manufacture if stored under 4°C. The opened kit should be stored according to components table.

 

原理-Assay Principles

Biotin ASSAY PRINCIPLES

Almost all monoclonal antibodies are glycosylated at (or around) Asn-297 of the Fc domain. While the glycans have different isoforms, the types that typically dominate are G0F, G1F&G2F (>90%). The A&Glink® Antibody Conjugation Kit utilizes the YTConju™ platform, a glycan remodeling strategy developed by Glyco-therapy Biotechnology Co., Ltd. for the construction of site-specific antibody conjugates.

The A&Glink® DAR2&4 Antibody Conjugation Kit integrates the procedure for constructing DAR2 conjugates and DAR4 conjugates in one kit, providing flexibility in DAR design.

To construct the DAR4 conjugates, galactose is first added to the terminal GlcNAc catalyzed by β-1,4-galactosyltransferase (GT) to form LacNAc. Then, α-1,3-fucosyltransferase (FT) recognizes LacNAc and transfers the Fuc-Payload to the GlcNAc of the LacNAc to form a conjugate with a theoretical DAR of 4.

Biotin ASSAY PRINCIPLES

To construct the DAR2 conjugates, glycans are first removed from the core GlcNAc catalyzed by endoglycosidase. Galactose is then added to the GlcNAc catalyzed by β-1,4-galactosyltransferase (GT) to form core LacNAc. Finally, α-1,3-fucosyltransferase (FT) recognizes LacNAc and transfers the Fuc-Payload to the GlcNAc of the LacNAc to form a conjugate with a theoretical DAR of 2.

The DAR4 and DAR2 conjugation procedures share the same FT, GT and GDP-Fuc-Payload. The main difference between these two procedures is the addition of an endoglycosidase.

These procedures are performed in a “one-pot” manner with only one purification step, which is highly convenient and efficient. Antibody conjugates produced with this kit generally exhibit high homogeneity, high stability and high hydrophilicity.

 

典型数据-Typical Data Please refer to DS document for the assay protocol.

Biotin TYPICAL DATA

ADC DAR value assessment by LC-TOF/MS

Biotin TYPICAL DATA

1.Analyst TF 1.8.1 Software was used to collect LC-TOF/MS data of samples in positive ion mode

2.PeakView was used for data processing and BioToolKit was used for deconvolution analysis.

3.DAR values are calculated using the following formula:

DAR4 =(920.12*4+77.42*3)/(920.12+77.42)=3.92

Biotin TYPICAL DATA

ADC DAR value assessment by LC-TOF/MS

Biotin TYPICAL DATA

1.Analyst TF 1.8.1 Software was used to collect LC-TOF/MS data of samples in positive ion mode

2.PeakView was used for data processing and BioToolKit was used for deconvolution analysis.

3.DAR values are calculated using the following formula:

DAR4 =(1138.27*2)/1138.27=2.00

 

Statement of Rights

AGLink products are co-developed by ACROBiosystems Co., Ltd. and Glyco-therapy Biotechnology Co., Ltd. based on Glyco-therapy's conjugation platform (YTConju™) and are not authorized for commercial use. The sale and use of AGLink products doesn't represent any forms of license or authorization of the attached technologies for developing any diagnostic, therapeutic or prophylactic products for commercial purposes.

Note of application

AGLink products are intended for research use only by the Buyer or its users and can not be used for any other purposes, including, but not limited to, use for any clinical diagnostic type use, in vitro or in vivo therapeutic use, prophylactic use, any type of consumption or application to human or animals.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
前沿进展
点击查看详细
相关产品
View All Biotin

消息提示

请输入您的联系方式,再点击提交!

确定